Devices/Safety Alert·openFDA/device

QUICK SET (UNOMEDICAL DEVICES S.A. DE C.V.) — Injury

MediumPublished Mar 31, 2026· AI-analyzed May 4, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

An injury event was reported involving the Quick Set device where a patient experienced leakage at the quick-release connection site in China. The patient reported being unable to achieve a tight connection at the quick-release point.

Who it affects

Manufacturers of infusion set systems, design engineers, and regulatory professionals responsible for post-market surveillance of insulin delivery accessories.

Why it matters

While the source provides limited detail, leakage in an infusion set presents a risk of under-delivery of medication. This report signals a potential mechanical failure or user interface issue at a critical connection point, which may necessitate a review of design tolerances or human factors validation for quick-release mechanisms.

Practical takeaway

Regulatory and QA teams should evaluate whether historical complaint data for this device shows a trend in connection failures. Review the clarity of instructions for use (IFU) regarding the quick-release mechanism to determine if user error or design fatigue contributes to suboptimal connections.

FDA source material

Event type: Injury. Device: QUICK SET by UNOMEDICAL DEVICES S.A. DE C.V.. REFERENCE NUMBER (B)(4). EVENT OCCURRED IN CHINA. IT WAS REPORTED THAT THE PATIENT EXPERIENCED INFUSION SET LEAKAGE EVENT ON (B)(6) 2026. THE LEAKAGE WAS AT THE QUICK RELEASE AS THE PATIENT WAS NOT ABLE TO CONNECT IT TIGHTLY. NO FURTHER INFORMATION AVAILABLE.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.